Spots Global Cancer Trial Database for oral
Every month we try and update this database with for oral cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT00522938 | Carcinoma, Non-... | CHR-2797 (tosed... erlotinib | 18 Years - | Chroma Therapeutics | |
| Safety and Efficacy of RK0202 in Oral Mucositis | NCT00230191 | Mouth Diseases Mouth Ulcers Oral Mucositis Head and Neck C... | RK-0202 | 18 Years - | RxKinetix | |
| Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | NCT00322400 | Locally Recurre... | Docetaxel Paclitaxel AMG 706 | 18 Years - | Amgen | |
| A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy | NCT01926444 | Pain Cancer Colonic Disease... | GIC-1001 | 40 Years - 70 Years | gicare Pharma Inc. | |
| Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | NCT00095186 | Carcinoma, Rena... | Recombinant Hum... | 18 Years - | Agennix | |
| A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors | NCT00046111 | Lung Cancer, Sm... Solid Tumor Can... | topotecan | 18 Years - | GlaxoSmithKline | |
| Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors | NCT01272570 | Breast Cancer Xerostomia | 50 Years - | University of Michigan | ||
| Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma | NCT01438450 | Hepatocellular ... | Oral Supportive | 12 Years - 70 Years | All India Institute of Medical Sciences, New Delhi | |
| Optimum Induction Therapy of Low-risk APL | NCT05832320 | Acute Promyeloc... Induction Thera... Oral | Etoposide Daunorubicin | 18 Years - 75 Years | Peking University People's Hospital | |
| Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib | NCT02226172 | Primary Myelofi... | Glasdegib (PF-0... Placebo | 18 Years - | Pfizer | |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies | NCT00621244 | Lymphoma Leukemia Multiple Myelom... | LBH589 | 18 Years - | Novartis | |
| Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer | NCT04720664 | Breast Cancer Metastatic Brea... Hormone Recepto... | SM-88 | 18 Years - | Georgetown University | |
| Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | NCT00049998 | Non-Small-Cell ... | topotecan | 18 Years - | GlaxoSmithKline | |
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT00522938 | Carcinoma, Non-... | CHR-2797 (tosed... erlotinib | 18 Years - | Chroma Therapeutics | |
| Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma | NCT00198315 | Head and Neck C... | Medpulser elect... Tumor surgical ... | 18 Years - | Inovio Pharmaceuticals | |
| Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects | NCT02054754 | Safety Tolerability Pharmacokinetic... Cancer | Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Placebo | 18 Years - 45 Years | e-Therapeutics PLC | |
| Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors | NCT01272570 | Breast Cancer Xerostomia | 50 Years - | University of Michigan | ||
| Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | NCT00076609 | Hepatocellular ... Liver Cancer | PHY906 capecitabine | 18 Years - 80 Years | PhytoCeutica | |
| Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older | NCT00535873 | Leukemia CLL Chronic Lymphoc... Small Lymphocyt... | Lenalidomide | 65 Years - | M.D. Anderson Cancer Center | |
| Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | NCT00095186 | Carcinoma, Rena... | Recombinant Hum... | 18 Years - | Agennix | |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer | NCT00097903 | Carcinoma Carcinoma, Non-... | Karenitecin (BN... | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy | NCT01926444 | Pain Cancer Colonic Disease... | GIC-1001 | 40 Years - 70 Years | gicare Pharma Inc. | |
| Trial of IIb Preserving Neck Dissection | NCT00847717 | Oral Cancer | Selective neck ... Conventional Ne... | 18 Years - 80 Years | Banaras Hindu University | |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies | NCT00621244 | Lymphoma Leukemia Multiple Myelom... | LBH589 | 18 Years - | Novartis | |
| Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | NCT00692354 | Advanced Solid ... | CHR-2797 (tosed... | 18 Years - | Chroma Therapeutics | |
| Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer | NCT04720664 | Breast Cancer Metastatic Brea... Hormone Recepto... | SM-88 | 18 Years - | Georgetown University | |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer | NCT00097903 | Carcinoma Carcinoma, Non-... | Karenitecin (BN... | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| Herbal Mouthrinse for Oral Mucositis Study | NCT01898091 | Oral Mucositis | Neem Mouthrinse Placebo Mouthri... | 18 Years - 89 Years | Medical University of South Carolina | |
| Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma | NCT00535951 | Carcinoma, Non-... Mesothelioma | LBH589 | 18 Years - | Novartis | |
| Trial of IIb Preserving Neck Dissection | NCT00847717 | Oral Cancer | Selective neck ... Conventional Ne... | 18 Years - 80 Years | Banaras Hindu University | |
| Safety of CHIR-258 (TKI258) in Advanced Solid Tumors | NCT01270906 | Neoplasms Cancer Tumors | CHIR-258 (TKI25... | 18 Years - | Novartis | |
| Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | NCT00430261 | Lung Cancer Adenocarcinoma | sunitinib | 18 Years - | Swedish Medical Center | |
| A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas | NCT03893682 | Chronic Lymphoc... Small Lymphocyt... Non-Hodgkin's L... | CG-806 | 18 Years - | Aptose Biosciences Inc. | |
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | NCT00522938 | Carcinoma, Non-... | CHR-2797 (tosed... erlotinib | 18 Years - | Chroma Therapeutics | |
| Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older | NCT00535873 | Leukemia CLL Chronic Lymphoc... Small Lymphocyt... | Lenalidomide | 65 Years - | M.D. Anderson Cancer Center | |
| Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects | NCT02054754 | Safety Tolerability Pharmacokinetic... Cancer | Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Dexanabinol Dos... Placebo | 18 Years - 45 Years | e-Therapeutics PLC | |
| Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer | NCT01653327 | Mucositis Head and Neck C... | Ketamine Placebo | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma | NCT01438450 | Hepatocellular ... | Oral Supportive | 12 Years - 70 Years | All India Institute of Medical Sciences, New Delhi | |
| Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | NCT00430261 | Lung Cancer Adenocarcinoma | sunitinib | 18 Years - | Swedish Medical Center | |
| A Study of ENMD-2076 in Ovarian Clear Cell Cancers | NCT01914510 | Ovarian Clear C... | ENMD-2076 | 18 Years - | University Health Network, Toronto | |
| The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) | NCT00043862 | Lung Cancer, Sm... Small Cell Lung... | topotecan | 18 Years - | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
